PHIO PHARMACEUTICALS

Serial Number 88170269
606

Registration Progress

Application Filed
Oct 26, 2018
Under Examination
May 21, 2019
Approved for Publication
Mar 26, 2019
Published for Opposition
Mar 26, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PHIO PHARMACEUTICALS
Previous Owner: PHIO PHARMACEUTICALS CORP.
Classes: 005

Trademark Image

PHIO PHARMACEUTICALS

Basic Information

Serial Number
88170269
Filing Date
October 26, 2018
Published for Opposition
March 26, 2019
Abandonment Date
June 27, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 27, 2022
Classes
005

Rights Holder

PHIO PHARMACEUTICALS CORP.

03
Address
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH, MA 01752

Ownership History

RXi Pharmaceuticals Corporation

Original Applicant
03
Marlborough, MA

PHIO PHARMACEUTICALS CORP.

New Owner Before Publication #1
03
MARLBOROUGH, MA

PHIO PHARMACEUTICALS CORP.

Owner at Publication
03
MARLBOROUGH, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Jun 27, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 27, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 12, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 19, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 12, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 12, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
May 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 11, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 11, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 8, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 6, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 6, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
May 6, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 22, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 20, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 20, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 20, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 26, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 26, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 6, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 11, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 28, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 9, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Therapeutic pharmaceuticals for use in the treatment of cancer

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"